KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Omega Healthcare Investors (OHI) Other Operating Expenses (2016 - 2026)

Omega Healthcare Investors' Other Operating Expenses history spans 16 years, with the latest figure at $3.0 million for Q1 2026.

  • On a quarterly basis, Other Operating Expenses fell 69.99% to $3.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $60.3 million, a 59.51% increase, with the full-year FY2025 number at $67.3 million, up 411.11% from a year prior.
  • Other Operating Expenses hit $3.0 million in Q1 2026 for Omega Healthcare Investors, down from $6.1 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for OHI hit a ceiling of $114.5 million in Q1 2022 and a floor of -$6.5 million in Q4 2023.
  • Historically, Other Operating Expenses has averaged $17.5 million across 5 years, with a median of $11.5 million in 2024.
  • Biggest five-year swings in Other Operating Expenses: tumbled 641.67% in 2023 and later soared 824.3% in 2025.
  • Tracing OHI's Other Operating Expenses over 5 years: stood at $1.2 million in 2022, then tumbled by 641.67% to -$6.5 million in 2023, then skyrocketed by 129.02% to $1.9 million in 2024, then skyrocketed by 222.0% to $6.1 million in 2025, then plummeted by 50.21% to $3.0 million in 2026.
  • Business Quant data shows Other Operating Expenses for OHI at $3.0 million in Q1 2026, $6.1 million in Q4 2025, and $28.3 million in Q3 2025.